Literature DB >> 8651234

Ethnic differences in immune responses to hepatitis B vaccine.

L C Hsu1, S R Lin, H M Hsu, W H Chao, J T Hsieh, M C Wang, C F Lu, Y H Chang, M S Ho.   

Abstract

A national vaccination program against hepatitis B virus (HBV) to immunize every newborn was initiated in Taiwan in 1986. A serologic survey of 1,812 fully vaccinated children residing in four aboriginal villages and four adjacent nonaboriginal Han Chinese rural villages was conducted in 1993. Children in three of the four aboriginal villages had significantly lower titers of antibody against hepatitis B surface antigen (anti-HBs) than did children in the nonaboriginal villages. Evaluation of cold chain operation for vaccine storage and transport suggested that cold chain failure was not responsible for the fact that children residing in the more remote aboriginal villages had lower mean titers of anti-HBs. However, children whose parents were both aborigines had lower anti-HBs mean titer than did children whose parents were both ethnic Han Chinese. Children of mixed parental origins had intermediate mean titer of anti-HBs. Serologic responses to Japanese encephalitis virus and diphtheria vaccines did not show such correlation with ethnic groups, indicating that the determinant for HBV hyporesponsiveness among the aboriginal children is distinct from that of other childhood vaccines. It was therefore concluded that host factors pertaining to ethnic origin might be responsible for the hyporesponsiveness to HBV vaccine in the aboriginal populations. This finding, if substantiated with further prospective studies, might provide possible means for more targeted trials to improve vaccine response and to reduce vaccine failure among these well-defined ethnic groups.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8651234     DOI: 10.1093/oxfordjournals.aje.a008805

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  14 in total

Review 1.  Systems immunogenetics of vaccines.

Authors:  Michael Mooney; Shannon McWeeney; Rafick-Pierre Sékaly
Journal:  Semin Immunol       Date:  2013-07-22       Impact factor: 11.130

Review 2.  Searching for the human genetic factors standing in the way of universally effective vaccines.

Authors:  Alexander J Mentzer; Daniel O'Connor; Andrew J Pollard; Adrian V S Hill
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-19       Impact factor: 6.237

Review 3.  Factors That Influence the Immune Response to Vaccination.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Clin Microbiol Rev       Date:  2019-03-13       Impact factor: 26.132

4.  Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa.

Authors:  Glenda E Gray; Ying Huang; Nicole Grunenberg; Fatima Laher; Surita Roux; Erica Andersen-Nissen; Stephen C De Rosa; Britta Flach; April K Randhawa; Ryan Jensen; Edith M Swann; Linda-Gail Bekker; Craig Innes; Erica Lazarus; Lynn Morris; Nonhlanhla N Mkhize; Guido Ferrari; David C Montefiori; Xiaoying Shen; Sheetal Sawant; Nicole Yates; John Hural; Abby Isaacs; Sanjay Phogat; Carlos A DiazGranados; Carter Lee; Faruk Sinangil; Nelson L Michael; Merlin L Robb; James G Kublin; Peter B Gilbert; M Juliana McElrath; Georgia D Tomaras; Lawrence Corey
Journal:  Sci Transl Med       Date:  2019-09-18       Impact factor: 17.956

Review 5.  Use of licensed vaccines for active immunization of the immunocompromised host.

Authors:  L A Pirofski; A Casadevall
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

6.  Epidemiology of hepatitis B in Canada.

Authors:  J Zhang; S Zou; A Giulivi
Journal:  Can J Infect Dis       Date:  2001-11

7.  Vaccine-Induced Anti-HBs Level in 5-6 Year-Old Malnourished Children.

Authors:  Mehran Karimi; Ali Raee; Behnam Baghianimoghadam; Mohammad Hossein Fallahzadeh
Journal:  Hepat Mon       Date:  2013-02-03       Impact factor: 0.660

8.  Chronic psychosocial stress: does it modulate immunity to the influenza vaccine in Hong Kong Chinese elderly caregivers?

Authors:  Samuel Yeung Shan Wong; Chun Kwok Wong; Frank Wan Kin Chan; Paul K S Chan; Karry Ngai; Stewart Mercer; Jean Woo
Journal:  Age (Dordr)       Date:  2012-07-08

9.  A comparison of treatment with adefovir and entecavir for chronic hepatitis B in China: The 2-year results of a prospective study: Adefovir versus Entercavir for Chronic Hepatitis B.

Authors:  En Qiang Chen; Tao You Zhou; Li Liu; Cong Liu; Ming Lei; Hong Tang
Journal:  Hepat Mon       Date:  2011-01       Impact factor: 0.660

Review 10.  Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?

Authors:  Gregory A Poland; Richard B Kennedy; Inna G Ovsyannikova
Journal:  PLoS Pathog       Date:  2011-12-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.